Trisha Pasricha
Trisha Pasricha is a physician and researcher working in the field of gastroenterology and neurogastroenterology. Her published research focuses on disorders of gut-brain interaction, motility disorders like irritable bowel syndrome, and gastrointestinal manifestations related to Parkinson's disease. She has also investigated clinical topics such as GLP-1 receptor agonists, endoscopic interventions, and behavioral risk factors for digestive health issues.
28 claims checked on air: 4 context 2 contradicted 18 supported 4 unverified
What they said on air - context
1 citing their own research
Forty percent of Americans experience bowel habits that disrupt their daily lives.
"they fall into that 40% of Americans whose bowel habits disrupt their daily lives." (said at 0:09:08)
Large population-based survey data in the United States demonstrate a high overall burden of gastrointestinal (GI) symptoms, with 61% of surveyed Americans reporting at least one GI symptom in the past week. Individual bowel-specific symptoms such as diarrhea and constipation were reported by approximately 20.2% and 19.7% of respondents, respectively. While gastrointestinal symptoms broadly affect a majority of the US population, citing a specific 40% figure for bowel habits that disrupt daily life requires context, as it approximates broader estimates of overall functional gastrointestinal disorders or combined symptom burdens rather than a single specific metric for life-disrupting bowel habits.
Colorectal cancer is the leading cause of cancer mortality among younger people.
"Colorectal cancer is leading the way right now, as of 2026, in terms of early onset colorectal cancers and mortality for younger people when it comes to different kinds of cancers." (said at 0:09:55)
According to surveillance data from the American Cancer Society published in CA: A Cancer Journal for Clinicians (2024), colorectal cancer has risen to become the leading cause of cancer mortality among men under age 50 in the United States (up from the fourth-leading cause in the late 1990s). However, among women under age 50, colorectal cancer is the second-leading cause of cancer death, following breast cancer.
Only about 20% of eligible adults aged 45 to 49 are actually obtaining screening colonoscopies.
"even for those people who are that 45 to 49-year range, who have been eligible for colorectal cancer screening for several years, only about 20% of them are actually getting their colonoscopies." (said at 0:13:11)
The claim that roughly 20% of adults aged 45 to 49 are obtaining colorectal cancer screening reflects baseline screening adherence rates immediately following the 2021 USPSTF guideline update (which lowered the recommended starting age from 50 to 45). In 2021, screening rates in this age group were documented at approximately 20% to 25.6%. However, screening uptake in this population has grown since then, reaching 31% to 36% nationally in 2023 and exceeding 50% in some regional health systems. Furthermore, these overall screening rates encompass both colonoscopies and stool-based modalities (such as FIT and FIT-DNA), rather than colonoscopies alone.
- context: Colorectal Cancer Test Completion among Adults Aged 45 to 75 in an Integrated Healthcare S… (Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2026)
"Colorectal cancer test completion increased from 61.8% (2021) to 70.8% (2024), with the largest increase in the 45- to 49-year age group (25.6% to 51.7%)." (abstract, results, passage verified)
pubmedfull study (doi) - context: Low colorectal cancer screening among adults aged 45-49 years in the US, 2023. (The American journal of managed care 2026)
"The rate of CRC screening was significantly lower among adults aged 45 to 49 years than among adults aged 50 to 54 years (36.1% vs 55.6%; P < .001)." (abstract, results, passage verified)
pubmedfull study (doi) - context: Colorectal Cancer Screening and Health-Related Social Needs in a National Sample of US Adu… (JAMA network open 2026) · cited 1x in the literature
"The proportion up to date with CRC screening was 63.91% (9758 adults) overall and increased with age, from 31.01% (586 adults) among adults aged 45 to 49 years to 64.24% (4539 adults) among those aged 50 to 64 years" (abstract, results, passage verified)
pubmedfull study (doi) - context: Colorectal Cancer Screening Uptake Across Age Groups in an Academic Health System. (American journal of preventive medicine 2026)
"Adults aged 45-49 years experienced increased screening adherence from 20% in 2021 to 46% in 2023." (abstract, results, passage verified)
pubmedfull study (doi)
Fiber supplements such as psyllium improve rectal sensitivity and reduce the frequency of fecal incontinence episodes.
"And they've done these studies where they found that actually just fiber supplements like psyllium can help improve that sensitivity so those episodes don't happen as often." (said at 1:01:22)
Randomized controlled trials confirm that psyllium fiber supplementation significantly reduces the frequency of fecal incontinence episodes in community-dwelling adults. However, this clinical improvement is primarily driven by psyllium's water-holding capacity and stool-bulking effect (forming a viscous stool gel that is easier to retain and evacuate) rather than a direct enhancement or repair of intrinsic rectal neuromuscular sensitivity, though a bulkier, more formed stool bolus may improve rectal mechanoreceptor perception.
Fact-checked episodes
Publications